LGALS13 and preeclampsia: Other groups, pioneered by Meiri et al. explored the clinical utilization of gal-13/PP13 immunoassays in maternal blood in normal and complicated pregnancies (183–186), as well as the potential use of gal-13/PP13 therapy for preeclampsia (187–193).